Technology | March 04, 2009

Gore Recognized as One of World’s Most Innovative Companies

March 4, 2009 - W. L. Gore & Associates has earned a spot on Fast Company magazine’s 2009 “Fast 50” list of the world’s most innovative companies, partly for its development of the GORE HELEX Septal Occluder.

Gore is ranked number 30 and appears in the magazine’s March issue.

Fast Company magazine highlights Gore’s Medical Products Division, which has provided creative therapeutic solutions to complex medical problems for three decades. During that time, more than 25 million innovative Gore medical devices have been implanted. The Gore Medical family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia repair, soft tissue reconstruction, staple line reinforcement and sutures for use in vascular, cardiac and general surgery.

One such device referred to in the “Fast 50” list was the GORE HELEX Septal Occluder for the treatment of atrial septal defect (ASD), a congenital heart defect that affects thousands of patients every year. The GORE HELEX Septal Occluder is the first device of its kind to use ePTFE, a biocompatible material that allows progressive tissue ingrowth, to help seal the defect. Approved by the FDA in 2006, the device is permanently implanted in a minimally invasive procedure through a catheter-based delivery system for the treatment of ASD. In December 2008, the GORE HELEX Septal Occluder became part of an FDA-approved clinical study designed to demonstrate the safety and effectiveness of the device for Patent Foramen Ovale (PFO) closure in patients with a PFO and history of cryptogenic stroke.

For more information:,

Related Content

Gore Cardioform ASD Occluder Receives FDA Approval
Technology | Structural Heart Occluders | June 10, 2019
W. L. Gore & Associates (Gore) announced the U.S. Food and Drug Administration’s (FDA’s) premarket approval (PMA)...
Le Bonheur Children's Hospital Implants First Abbott Amplatzer Piccolo Occluder
News | Structural Heart Occluders | February 13, 2019
Le Bonheur Children's Hospital cardiologists in Memphis, Tenn., implanted the Amplatzer Piccolo Occluder, the world's...
FDA Approves Abbott's Amplatzer Piccolo Occluder
News | Structural Heart Occluders | January 16, 2019
Abbott announced the U.S. Food and Drug Administration (FDA) approved the Amplatzer Piccolo Occluder to treat patent...
FDA Approves Gore Cardioform Septal Occluder for PFO Closure Prevent Recurrent Ischemic Stroke
Technology | Structural Heart Occluders | April 03, 2018
April 3, 2018 — Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen oval
University of Alabama at Birmingham, Amplatzer PFO Occluder, first implementation
News | Structural Heart Occluders | February 15, 2017
Doctors at the University of Alabama at Birmingham have implemented the first U.S. Food and Drug Administration (FDA)-...
Amplatzer PFO Occluder, St. Jude Medical, Baylor Heart and Vascular Services, Fort Worth, Texas, first patients
News | Structural Heart Occluders | February 01, 2017
Baylor Heart and Vascular Services at Fort Worth in November became the first program in Texas to implant the Amplatzer...
Overlay Init